Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-17

Clinical Trial Update: A Comparative Evaluation of Mosapride Versus Metoclopramide for Enteral Feeding Intolerance in Critically Ill Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial protocol comparing mosapride versus metoclopramide for enteral feeding intolerance in critically ill patients; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metoclopramide (metoclopramide)
  • Mosapride (mosapride)

Snippet

Sponsor: Ain Shams University | Conditions: Enteral Feeding Intolerance | Phase 3 | Status: NOT_YET_RECRUITING